Compare Davita Inc (DVA) vs ProShares UltraPro Short QQQ ETF (SQQQ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Davita Inc vs ProShares UltraPro Short QQQ ETF — how do they compare? Davita Inc trades at $175.04 (market cap $11.29B), while ProShares UltraPro Short QQQ ETF trades at $32.64 (market cap $2.23B). The key difference: Davita Inc is far larger — about 5.1× ProShares UltraPro Short QQQ ETF's market cap, and Davita Inc is trading nearer its 52-week high, ProShares UltraPro Short QQQ ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Davita Inc for 113 Days and ProShares UltraPro Short QQQ ETF for 12 Days on average.
| DVA | SQQQ | |
|---|---|---|
Market Cap | $11.29B | $2.23B |
Volume | 582,204 | 60,436,012 |
Sector | Health | Leveraged / Inverse |
52-Week High | $240.96 | $89.43 |
52-Week Low | $103.87 | $31.83 |
Typical Hold Time | 113 Days | 12 Days |
Enterprise Value | $24.01B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DaVita (DVA) trades at $176.78, down 2.01% today, showing technical bearish signals with price near key support at $175. Fundamentally, the company demonstrates solid earnings performance with three consecutive quarterly beats and attractive valuation metrics including a P/E of 14.98 and P/S of 0.88. Recent expansion of value-based care partnerships with Humana positions the company for continued growth in kidney care services.
The stock presents a compelling value opportunity with analyst consensus target of $235.67 offering 33% upside potential, though investors face risks from regulatory pressures and narrowing profit margins. Warren Buffett's significant ownership (45%) and institutional buying activity provide confidence, but the bearish technical outlook and mixed analyst ratings (43% Buy, 52% Hold) suggest cautious optimism is warranted.
SQQQ (ProShares UltraPro Short QQQ) trades at $32.08, up 0.79% today, as a 3x leveraged inverse ETF designed to profit from declines in the Nasdaq-100. Technical indicators show a bearish trend with moving averages signaling sell pressure, though oscillators suggest potential near-term oversold conditions. The ETF serves as a hedging tool against tech sector weakness, with recent news highlighting its strategic use alongside long QQQ positions.
Outlook remains tied to Nasdaq-100 performance; further tech sector declines could benefit SQQQ, but leveraged decay and volatility pose significant risks. Investors using SQQQ for hedging should monitor market sentiment and sector-specific catalysts. The ETF's structure makes it unsuitable for long-term holdings due to compounding effects in volatile markets.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Davita Inc
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government (primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
Read more on DVA →About ProShares UltraPro Short QQQ ETF
SQQQ is a leveraged inverse ETF that seeks daily investment results, before fees and expenses, that correspond to three times the inverse (-3x) of the daily performance of the Nasdaq-100 Index. It is a tactical trading tool designed for sophisticated investors to profit from or hedge against declines in large-cap technology and growth stocks. Due to its daily reset and the effects of compounding, it is intended for short-term use and carries significant risk if held during periods of high market volatility.
Read more on SQQQ →
